MY102991A - Medicaments for treating hypertension. - Google Patents

Medicaments for treating hypertension.

Info

Publication number
MY102991A
MY102991A MYPI87003001A MYPI19873001A MY102991A MY 102991 A MY102991 A MY 102991A MY PI87003001 A MYPI87003001 A MY PI87003001A MY PI19873001 A MYPI19873001 A MY PI19873001A MY 102991 A MY102991 A MY 102991A
Authority
MY
Malaysia
Prior art keywords
medicaments
treating hypertension
compound
formula
combination
Prior art date
Application number
MYPI87003001A
Inventor
P Horovitz Zola
Rubin Bernard
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25343256&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY102991(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of MY102991A publication Critical patent/MY102991A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A METHOD FOR REDUCING BLOOD PRESSURE COMPRISES ADMINISTERING A COMBINATION OF A DIURETIC COMPOUND AND A COMPOUND HAVING THE GENERAL FORMULA (FORMULA 1)
MYPI87003001A 1977-12-27 1987-10-31 Medicaments for treating hypertension. MY102991A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86442877A 1977-12-27 1977-12-27
DE2854316A DE2854316C3 (en) 1977-12-27 1978-12-15 Medicines for the treatment of high pressure
GB7849703A GB2010675B (en) 1977-12-27 1978-12-21 Treating hypertension and medicaments therefor

Publications (1)

Publication Number Publication Date
MY102991A true MY102991A (en) 1993-03-31

Family

ID=25343256

Family Applications (2)

Application Number Title Priority Date Filing Date
MY240/83A MY8300240A (en) 1977-12-27 1983-12-30 Medicamens for treating hypertension
MYPI87003001A MY102991A (en) 1977-12-27 1987-10-31 Medicaments for treating hypertension.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MY240/83A MY8300240A (en) 1977-12-27 1983-12-30 Medicamens for treating hypertension

Country Status (30)

Country Link
JP (1) JPS54110333A (en)
AR (1) AR230378A1 (en)
AU (1) AU526239B2 (en)
BE (1) BE873092A (en)
CA (1) CA1120400A (en)
CH (1) CH642542A5 (en)
DE (1) DE2854316C3 (en)
DK (1) DK578778A (en)
EG (1) EG14178A (en)
FI (1) FI783991A7 (en)
FR (1) FR2413089A1 (en)
GB (1) GB2010675B (en)
GR (1) GR72951B (en)
HK (1) HK45483A (en)
HU (1) HU178747B (en)
IE (1) IE48306B1 (en)
IL (1) IL56281A (en)
IT (1) IT1202811B (en)
KE (1) KE3235A (en)
LU (1) LU80709A1 (en)
MY (2) MY8300240A (en)
NL (2) NL192870C (en)
NO (1) NO784357L (en)
NZ (1) NZ189159A (en)
PH (1) PH22111A (en)
PL (1) PL212188A1 (en)
PT (1) PT68983A (en)
SE (1) SE445173B (en)
SG (1) SG41482G (en)
ZA (1) ZA786948B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5829950B2 (en) * 1978-10-05 1983-06-25 ウェルファイド株式会社 Cyclic iminocarboxylic acid derivatives and their salts
US4350704A (en) 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
US4482725A (en) * 1980-04-03 1984-11-13 E. R. Squibb & Sons, Inc. S-Acylation products of mercaptoacyl amino acids and carboxyl group containing diuretics
US4344949A (en) 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4532342A (en) * 1981-02-20 1985-07-30 Warner-Lambert Company N-substituted amino acids as intermediates in the preparation of acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4552889A (en) * 1983-06-09 1985-11-12 Eli Lilly And Company 3-Mercaptomethyl-2-oxo-1-pyrrolidine acetic acids and use for hypertension
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
DE3532036A1 (en) * 1985-09-09 1987-03-26 Hoechst Ag PHARMACEUTICAL PREPARATION FOR TREATING HIGH PRESSURE
DK9200258U4 (en) * 1992-03-11 1993-07-23 Merck & Co Inc Pharmaceutical preparation containing enalapril for use in hypertension
WO1996024358A1 (en) * 1995-02-10 1996-08-15 G.D. Searle & Co. Use of low dose amount of spironolactone for treatment of cardiovascular disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU509899B2 (en) * 1976-02-13 1980-05-29 E.R. Squibb & Sons, Inc. Proline derivatives and related compounds

Also Published As

Publication number Publication date
DE2854316A1 (en) 1979-07-05
IT1202811B (en) 1989-02-09
NO784357L (en) 1979-06-28
FI783991A7 (en) 1979-06-28
IL56281A0 (en) 1979-03-12
NL980017I1 (en) 1998-07-01
FR2413089B1 (en) 1980-12-26
DE2854316C2 (en) 1989-08-10
PL212188A1 (en) 1980-02-11
SG41482G (en) 1985-01-11
FR2413089A1 (en) 1979-07-27
DE2854316C3 (en) 1994-12-22
GB2010675B (en) 1982-06-16
SE445173B (en) 1986-06-09
AR230378A1 (en) 1984-04-30
DK578778A (en) 1979-06-28
IT7831266A0 (en) 1978-12-22
NL7812164A (en) 1979-06-29
NZ189159A (en) 1984-12-14
NL192870B (en) 1997-12-01
CA1120400A (en) 1982-03-23
IL56281A (en) 1983-05-15
HU178747B (en) 1982-06-28
IE782413L (en) 1979-06-27
GB2010675A (en) 1979-07-04
BE873092A (en) 1979-06-27
GR72951B (en) 1984-01-17
AU4204178A (en) 1979-07-05
EG14178A (en) 1984-06-30
SE7813277L (en) 1979-06-28
ZA786948B (en) 1980-04-30
IE48306B1 (en) 1984-12-12
PT68983A (en) 1979-01-01
HK45483A (en) 1983-10-28
PH22111A (en) 1988-06-01
CH642542A5 (en) 1984-04-30
AU526239B2 (en) 1982-12-23
JPS54110333A (en) 1979-08-29
MY8300240A (en) 1983-12-31
NL192870C (en) 1998-04-02
JPS647045B2 (en) 1989-02-07
LU80709A1 (en) 1979-04-13
KE3235A (en) 1982-11-05

Similar Documents

Publication Publication Date Title
DE3364150D1 (en) Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
MY100343A (en) Amide derivative and external medicament comprising same
FI860285A0 (en) 6-TIOXANTINDERIVAT.
ES525786A0 (en) A PROCEDURE FOR PREPARING DERIVATIVES OF PIRAZOLO (3,4-B) PIRIDINE
MY102991A (en) Medicaments for treating hypertension.
JPS5439098A (en) Mitomycin c derivatives
ES472847A1 (en) 2-Bromo-ergosine and its acid addition salts, method for its preparation and its application as a medicine.
BG44379A3 (en) Method for preparing of 9- chlor- 1, 5- benzothiazepine derivatives
EP0319962A3 (en) Piperidinyl methanol derivatives for the treatment of anxiety
ES475361A1 (en) Pyridine derivative, its preparation and use
EP0122831A3 (en) Benzothiazole-2-sulfonamide derivatives for the topical treatment of elevated intraocular pressure
AU5516590A (en) Dehydrocholecalciferol derivatives
HK17880A (en) N-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoylbenzamide and derivatives
CA1262912C (en) Tetrahydrofuranyl substituted prostaglandin analogs
NZ184140A (en) Pharmaceutical compositions based on a heterocyclic compound:treatment of skin disorders
CA1268468C (en) Thiabicycloheptane substituted prostaglandin analogs
AU6243186A (en) A pharmaceutical composition for the treatment of high blood pressure
EP0257631A3 (en) Oxolabdanes, a process for their preparation and their use as medicaments
GB2197199B (en) Medicament for treatment of pregnancy-induced hypertension.
AU519087B2 (en) Bicyclo (3, 2, 0) heptane derivatives
ZA913920B (en) Therapeutic compound
ZA842665B (en) Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
UA16000A1 (en) Method for treatment of hypotrophy in piglings
JO1493B1 (en) Pharmaceutical compositions for the treatment of high blood pressure
ZA842958B (en) Benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure